CAPITAL FUND MANAGEMENT S.A.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1323645
PARIS, I0
Position in SUPN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,535,968
+$421,123 QoQ
Shares Held
29,715
+27.4% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $92,308,096 across 12 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
48,964 | $29,034,672 | |
| 2 | ZTS |
Zoetis Inc.
|
190,415 | $22,508,957 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
149,631 | $19,712,387 | |
| 4 | ALKS |
Alkermes plc.
|
243,043 | $8,594,000 | |
| 5 | HLN |
Haleon plc
|
421,051 | $4,214,720 | |
| 6 | PRGO |
PERRIGO Co plc
|
277,003 | $2,975,012 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
29,715 | $1,535,968 | |
| 8 | LQDA |
Liquidia Corp
|
34,222 | $1,291,538 |
All Filings in SUPN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,535,968 | 29,715 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $1,114,845 | 23,328 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||